Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
#ObesityResearch #ClinicalDevelopment #DrugDiscovery To view or add a comment, sign in What if the biggest advancement in obesity care isn't a new medication
3).[56], [57], [58] While the ideal algorithm to identify patients with NASH remains to be found, this approach provides some general guidance that may help to stratify patients into high, intermediate and low likelihood of meeting enrollment criteria
Both groups eventually reached the same maintenance doses, but the path to get there was dramatically different in terms of comfort and adherence
The research was primarily funded by CHDI Foundation and the Huntingtons Disease Association
doi:10.2337/db10-0474 114
Cited here as scientific record of the compounds receptor-pharmacology characterization
